series-b
Stage
2020
Founded
3
Investors
About
Indigo develops a continuous multi-metabolite monitoring (CMM) system, a subcutaneously implanted sensor that measures glucose, ketone, and lactate levels in people with diabetes, eliminating the need for external devices or frequent finger pricks.
Explore Indigo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.